A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)
dc.contributor.author | Zeuzem, Stefan | |
dc.contributor.author | Bock, Thomas | |
dc.contributor.author | Dienes, Hans P. | |
dc.contributor.author | Bozkaya, Hakan | |
dc.contributor.author | Degertekin, Ha | |
dc.contributor.author | Gurel, Sa. | |
dc.contributor.author | Zachou, Kalliopi | |
dc.contributor.author | Manns, Michael P. | |
dc.contributor.author | Yurdaydin, Cihan | |
dc.contributor.author | Wedemeyer, Heiner | |
dc.contributor.author | Dalekos, George | |
dc.contributor.author | Erhardt, Alexander | |
dc.contributor.author | Cakaloglu, Ya | |
dc.date.accessioned | 2021-03-05T13:36:22Z | |
dc.date.available | 2021-03-05T13:36:22Z | |
dc.identifier.citation | Yurdaydin C., Wedemeyer H., Dalekos G., Erhardt A., Cakaloglu Y., Degertekin H., Gurel S., Zeuzem S., Zachou K., Bozkaya H., et al., "A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)", 57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, Amerika Birleşik Devletleri, 27 - 31 Ekim 2006, cilt.44 | |
dc.identifier.other | av_b2fb8f0a-c7af-4d5f-a692-614fb8fa037e | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/119224 | |
dc.language.iso | eng | |
dc.subject | Gastroenteroloji-(Hepatoloji) | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.title | A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT) | |
dc.type | Bildiri | |
dc.contributor.department | , , | |
dc.identifier.volume | 44 | |
dc.contributor.firstauthorID | 132869 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Bildiri [64839]